Zhongyang Liu

发表

Co-administration of dual-targeting nanoparticles with penetration enhancement peptide for antiglioblastoma therapy.

Quanyin Hu, Xiaoling Gao, L. Yao, 2014, Molecular pharmaceutics.

Low molecular weight protamine-functionalized nanoparticles for drug delivery to the brain after intranasal administration.

Xinguo Jiang, Lei Yao, Zhiqing Pang, 2011, Biomaterials.

F3 peptide-functionalized PEG-PLA nanoparticles co-administrated with tLyp-1 peptide for anti-glioma drug delivery.

Quanyin Hu, Xin-guo Jiang, Xiaoling Gao, 2013, Biomaterials.

PEG-co-PCL nanoparticles modified with MMP-2/9 activatable low molecular weight protamine for enhanced targeted glioblastoma therapy.

Quanyin Hu, Xiaoling Gao, L. Yao, 2013, Biomaterials.

Preparation and characterization of paclitaxel-loaded DSPE-PEG-liquid crystalline nanoparticles (LCNPs) for improved bioavailability.

Quanyin Hu, Xin-guo Jiang, L. Yao, 2012, International journal of pharmaceutics.

Determination of Fulvestrant in Rat Plasma by LC–MS–MS: Application to a Pharmacokinetic Study

Xin-guo Jiang, Huimin Xia, Jun Chen, 2011 .

Lipid-based liquid crystalline nanoparticles as oral drug delivery vehicles for poorly water-soluble drugs: cellular interaction and in vivo absorption

Quanyin Hu, Huimin Xia, Jun Chen, 2012, International journal of nanomedicine.

Lactoferrin-modified PEG-co-PCL nanoparticles for enhanced brain delivery of NAP peptide following intranasal administration.

Quanyin Hu, Xin-guo Jiang, L. Yao, 2013, Biomaterials.

Determination of sulphasalazine and its main metabolite sulphapyridine and 5-aminosalicylic acid in human plasma by liquid chromatography/tandem mass spectrometry and its application to a pharmacokinetic study.

Xin-guo Jiang, Huimin Xia, Jun Chen, 2011, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

The influence of the penetrating peptide iRGD on the effect of paclitaxel-loaded MT1-AF7p-conjugated nanoparticles on glioma cells.

Quanyin Hu, Xin-guo Jiang, L. Yao, 2013, Biomaterials.

Penetratin-functionalized PEG-PLA nanoparticles for brain drug delivery.

Xinguo Jiang, Lei Yao, Zhiqing Pang, 2012, International journal of pharmaceutics.

B6 peptide-modified PEG-PLA nanoparticles for enhanced brain delivery of neuroprotective peptide.

Quanyin Hu, Xin-guo Jiang, L. Yao, 2013, Bioconjugate chemistry.

Glioma therapy using tumor homing and penetrating peptide-functionalized PEG-PLA nanoparticles loaded with paclitaxel.

Quanyin Hu, Xin-guo Jiang, L. Yao, 2013, Biomaterials.

Activatable cell penetrating peptide-conjugated nanoparticles with enhanced permeability for site-specific targeting delivery of anticancer drug.

Quanyin Hu, L. Yao, Huimin Xia, 2013, Bioconjugate chemistry.

PEG-co-PCL nanoparticles modified with MMP-2/9 activatable low molecular weight protamine for enhanced targeted glioblastoma therapy.

Quanyin Hu, L. Yao, Huimin Xia, 2013, Biomaterials.

B6 peptide-modified PEG-PLA nanoparticles for enhanced brain delivery of neuroprotective peptide.

Quanyin Hu, Xin-guo Jiang, L. Yao, 2013, Bioconjugate chemistry.

Preparation and characterization of paclitaxel-loaded DSPE-PEG-liquid crystalline nanoparticles (LCNPs) for improved bioavailability.

Quanyin Hu, Xin-guo Jiang, L. Yao, 2012, International journal of pharmaceutics.